Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide treatment for patients who have relapsed NHL or
refractory NHL, and to determine the effectiveness and safety of the Zevalin and Rituxan
regimens or Rituxan therapy alone on your disease.